The Czechoslovak Group (CSG) unveiled two significant operational milestones this week – a ceremonial first spade in the ground for its Iowa artillery complex and a maiden anti-drone munition order from the Italian army – yet the stock continued its downward trajectory, underscoring a deepening rift between industrial achievement and market sentiment. Shares initially fell 1.68% to €13.69 on Wednesday before accelerating into the close, settling at €13.51 – a 2.96% decline from the previous day’s €13.92 finish. The dual announcements from CSG’s expanding transatlantic footprint did little to counter the lingering after-effects of a short-seller report that wiped 28% off the stock in early May, leaving the market capitalisation at roughly €13.91 billion, barely half the €25 billion valuation at the January IPO in Amsterdam.
The company’s U.S. expansion took a concrete step with the groundbreaking of the “Future Artillery Complex” in Iowa, a facility expected to be fully operational within 48 months of contract award. CSG’s European technicians are already on site to transfer decades of manufacturing expertise, supporting a ramp-up in large-calibre ammunition production from over 800,000 rounds annually – already achieved by the end of the first quarter of 2026 – to around 850,000 by December of that year. Separately, subsidiary Fiocchi Munizioni unveiled a new tungsten-pellet projectile for the standard NATO 5.56×45 mm calibre, designed to give infantry squads a lightweight anti-drone capability effective between 10 and 70 metres. The Italian army promptly placed an initial order after live demonstrations with special forces and the national counter-drone centre in Sabaudia, marking the technology’s domestic market entry.
Despite these developments, the stock remains under heavy pressure. From its January record of €36.05, the share has shed over 62%, while the 50-day moving average of €15.29 and the 100-day average of €20.23 both sit well above current levels. The 14-day relative strength index cooled to 42.4 as selling steadied, but annualised 30-day volatility remains elevated above 52%, indicating no let-up in choppy trading. Investor confidence has been battered not only by the short-seller allegations but also by governance questions at certain subsidiaries, a recurring theme that has blunted the impact of otherwise positive operational news.
Should investors sell immediately? Or is it worth buying CSG?
However, the political backdrop remains strongly supportive. NATO allies committed at the 2025 summit in The Hague to allocate 5% of GDP to defence annually through 2035, while the European Union’s SAFE instrument has unlocked up to €150 billion in credit lines for defence investments, explicitly favouring European suppliers. For CSG, this translates into sustained demand for its expanding product range, from artillery shells to counter-drone munitions, and for its vertically integrated model – bolstered by the integration of the Kinetic Group (formerly Vista Outdoor’s ammunition business) and technology transfers to partner MESKO in Poland. The company has also been recruiting senior talent from Rheinmetall and Northrop Grumman, signalling long-term ambitions.
The next major catalyst arrives on 7 August, when CSG publishes its half-year results. Analysts will scrutinise whether rising defence budgets in Europe and the United States are translating into margin expansion that could finally reverse the stock’s trajectory. Until then, the market appears to be looking past concrete factory openings and new contracts, fixated instead on the credibility damage inflicted in May and the unresolved governance concerns that continue to weigh on the shares.
Ad
CSG Stock: Buy or Sell?! New CSG Analysis from July 15 delivers the answer:
The latest CSG figures speak for themselves: Urgent action needed for CSG investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 15.
CSG: Buy or sell? Read more here...
